To assess the course of COVID-19 in hospitalized patients, innate immune responses can be monitored in the peripheral blood by measuring concentrations of the master inducer of the acute-phase response, interleukin (IL)-6, and its down-stream effectors, such as C-reactive protein (CRP) and ferritin. This evidence concerns the gene IL6 and COVID-19.